LeonaBio (LONA) Other Accumulated Expenses (2019 - 2026)

LeonaBio (LONA) has 8 years of Other Accumulated Expenses data on file, last reported at $1.3 million in Q1 2026.

• Other Accumulated Expenses for Q1 2026 came in at $1.3 million, down 46.75% year-over-year; the trailing twelve-month figure through Mar 2026 was $1.3 million (down 46.75% YoY), and the FY2025 annual result was $2.0 million, down 41.24% from the prior year.
• Other Accumulated Expenses eased to $1.3 million in Q1 2026 per LONA's latest filing, from $2.0 million in the prior quarter.
• Over five years, Other Accumulated Expenses peaked at $11.9 million in Q4 2023 and troughed at $738000.0 in Q3 2025.
• A 5-year average of $5.7 million and a median of $5.1 million in 2022 frame the typical range for Other Accumulated Expenses.
• The sharpest annual moves came in 2023 and 2025: Other Accumulated Expenses surged 210.07% in 2023, then sank 90.86% in 2025.
• A 5-year view of Other Accumulated Expenses shows it stood at $3.8 million in 2022, then surged by 210.07% to $11.9 million in 2023, then sank by 71.27% to $3.4 million in 2024, then slumped by 41.24% to $2.0 million in 2025, then slumped by 33.7% to $1.3 million in 2026.
• Business Quant data shows LONA's Other Accumulated Expenses at $1.3 million in Q1 2026, $2.0 million in Q4 2025, and $738000.0 in Q3 2025.